Jay Flatley
From 1999 to 2016, Flatley was CEO of Illumina, executive chairman through 2019, and now is the chairman of the board. Illumina, provides integrated systems for the analysis of genetic variation and biological function. Previously, he was VP of engineering and strategic planning at Plexus Computers, and EVP at Manning Technologies. He currently serves on the boards of Coherent, Denali, Iridia and the Wellcome Trust Leap Fund, and is on the board of trustees for The Salk Institute.
- March 2020
Added to: Zymergen - Emerville, CA
Zymergen is a science and material innovation company. A World Economic Forum Tech Pioneer, they partner with nature to create never-before imagined materials and products across industries, from agriculture to consumer electronics, personal care to pharmaceuticals, and more. Zymergen's clients have sold over $1 billion worth of products using their microbial strains.